Who Owns TLIS?
TALIS BIOMEDICAL CORP — Institutional Ownership & 13F Holdings
$0.00
+0.00 (+0.00%)
Market Cap
—
Shares Outstanding
—
Institutional Holders
17
Total Inst. Value
$152.5B
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2024
Top 10 Institutional Holders(Q1 2024)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $152.5B | 17,431 |
| 2 | BAKER BROS. ADVISORS LP | $4.4M | 508,323 |
| 3 | DME Capital Management, LP | $1.3M | 149,052 |
| 4 | PRELUDE CAPITAL MANAGEMENT, LLC | $131K | 14,928 |
| 5 | Larson Financial Group LLC | $123K | 14 |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $90K | 10,299 |
| 7 | Tower Research Capital LLC (TRC) | $8K | 927 |
| 8 | MORGAN STANLEY | $6K | 635 |
| 9 | UBS Group AG | $1K | 120 |
| 10 | VANGUARD GROUP INC | $271 | 31,013 |
Famous Fund Managers
Frequently Asked Questions
How many institutional investors hold TLIS?
As of Q1 2024, 17 institutional investors report holding TLIS (TALIS BIOMEDICAL CORP) in their 13F filings.
Which hedge fund owns the most TLIS?
The largest institutional holder of TLIS is SUSQUEHANNA INTERNATIONAL GROUP, LLP with $152.5B in shares.
Are institutions buying or selling TLIS?
This quarter, 17 institutions opened new positions in TLIS and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.